-+ 0.00%
-+ 0.00%
-+ 0.00%

LENZ THERAPEUTICS ANNOUNCES MFDS SUBMISSION OF NEW DRUG APPLICATION FOR LNZ100 (VIZZ™) IN SOUTH KOREA FOR THE TREATMENT OF PRESBYOPIA

Reuters·12/01/2025 13:30:00

Please log in to view news